Dr. Brahm Hillel Segal, MD

Dr. Segal practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Segal's NPI, 1316928468, was assigned on November 7, 2005. Dr. Segal graduated from Albert Einstein College of Medicine in 1992. Dr. Segal holds Florida license ME171230.

Dr. Segal's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Segal's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Segal to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Segal practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Segal's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Segal is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Segal's licenses on file in 3 states: Florida, New York and Maryland.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection, lyme disease and pneumonia among the conditions Dr. Segal treats.

CMS data shows 150 Medicare services from Dr. Segal across 5 procedure codes in 2024, for 72 Medicare patients. Medicare paid $10,420 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Segal in 2024. The largest group is 65 to 74, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Segal's median patient age at 67, with 40% women.

In 2024, Dr. Segal wrote 171 Medicare Part D claims for 40 patients. 82% of them were for generic drugs. CMS names the drug for 81 of them, across 5 drugs with 11 or more claims each, at $25,166 in total drug cost. In 2023, CMS named 69 claims across 5 drugs.

Dr. Segal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 128 papers to Dr. Segal, published from 2002 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Antifungal Agents, NADPH Oxidases and Aspergillosis. Dr. Segal has published most often in Clin Infect Dis. Dr. Segal's most frequent co-authors are Philip Louis McCarthy, MD, Thomas F. Patterson, MD and David Alec Stevens, MD.

Dmand AI links Dr. Segal to 2 clinical trials. Conditions studied include Hematologic Neoplasms, Myelodysplastic-Myeloproliferative Diseases and Bone Marrow Diseases.

CMS Open Payments shows 28 general payments to Dr. Segal from 4 drug and device companies from 2018 to 2024. Consulting fees make up the largest share, 91% of the total. Merck Sharp & Dohme Corporation paid the most, $33,293.

Dmand AI lists 3 awards for Dr. Segal, most recently America's Top Doctors in 2014.

Dr. Segal graduated from Albert Einstein College of Medicine in 1992.

Dr. Segal is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.